SAFEGUARD SCIENTIFICS Business Summary

Safeguard Scientifics Inc. (SFES) operates as a specialty finance firm currently executing a multi-year strategy to maximize the value of its legacy portfolio through orderly liquidation and capital return. Historically a venture capital pioneer, the company’s current business model focuses exclusively on the monetization of its remaining ownership interests in technology-driven enterprises across three primary segments: healthcare (digital health and therapeutics), financial technology, and enterprise software. Revenue is generated through exit events, such as the sale of partner companies or secondary market transactions, with proceeds distributed to shareholders after satisfying debt and operational obligations. In the competitive landscape, Safeguard is positioned alongside specialty finance and asset management firms like Great Elm Group (GEG), Lakeshore Acquisition III (LCCC), and Papaya Growth Opportunity Corp. I (PPYA). Unlike these active investment vehicles, SFES distinguishes itself as a liquidating entity that ceased new capital deployments in 2018 to prioritize the wind-down of its mature asset base. The company was founded in 1953 by the late Warren V. "Pete" Musser and Frank Diamond, who famously utilized Safeguard to provide seed funding for future giants such as Comcast, QVC, and Novell. As of March 2026, the leadership team is led by CEO Mark Dow, a managing director at Rock Creek Advisors who was appointed in early 2024 to oversee the firm’s final stages of operational streamlining and asset monetization. He is supported by Senior Vice President and CFO Mark Herndon and General Counsel G. Matthew Barnard. The Board of Directors, chaired by Dr. Robert J. Rosenthal, includes notable activist investor Joseph M. Manko Jr. of The Horton Fund, whose involvement followed a significant push by institutional shareholders—including Sierra Capital and Maplewood Capital—to align management incentives with shareholder returns during the company's liquidation phase.